Treatment for patients with type 3 von Willebrand disease and alloantibodies: a case report

被引：20
|
作者：
Franchini, M. [1 ]
Gandini, G. [1 ]
Giuffrida, A. [1 ]
De Gironcoli, M. [1 ]
Federici, A. B. [2 ,3 ,4 ]
机构：
[1] City Hosp, Transfus & Hemophilia Ctr, Verona, Italy
[2] Univ Milan, Angelo Bianchi Bonomi Hemophilia, IRCCS Maggiore Hosp, Milan, Italy
[3] Univ Milan, Thrombosis Ctr, IRCCS Maggiore Hosp, Milan, Italy
[4] Univ Milan, Dept Med & Med Specialties, IRCCS Maggiore Hosp, Milan, Italy
来源：
HAEMOPHILIA | 2008年 / 14卷 / 03期
关键词：
D O I：
10.1111/j.1365-2516.2008.01668.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：645 / 646
页数：2
相关论文
共 50 条
  • [1] von Willebrand factor alloantibodies in type 3 von Willebrand disease
    Kotnik, Barbara Faganel
    Strandberg, Karin
    Debeljak, Marusa
    Kitanovski, Lidija
    Jazbec, Janez
    Benedik-Dolnicar, Majda
    Bakija, Alenka Trampus
    BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (01) : 77 - 79
  • [2] Management of pregnancy in type 3 von Willebrand disease with alloantibodies
    Scott, Martin
    Hay, Charles R. M.
    Elkhalifa, Shuayb
    Tower, Clare
    Cocker, Michael
    Thachil, Jecko
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 (03) : 440 - 442
  • [3] Navigating the challenges: a case report on managing a complicated postpartum course in type 3 von Willebrand disease with alloantibodies
    Zwet, Konrad van der
    Galen, Karin P. M. van
    Evers, Annemiek C. C.
    Fischer, Kathelijn
    Schutgens, Roger E. G.
    Vulpen, Lize F. D. van
    Zwet, Konrad van der
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (03)
  • [4] First report of inhibitory von Willebrand factor alloantibodies in type 2B von Willebrand disease
    Baaij, Marije
    van Galen, Karin P. M.
    Urbanus, Rolf T.
    Nigten, Jeannet
    Eikenboom, Jeroen H. C.
    Schutgens, Roger E. G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (03) : 424 - 427
  • [5] Alloantibodies in von Willebrand Disease
    Franchini, Massimo
    Mannucci, Pier Mannuccio
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2018, 44 (06): : 590 - 594
  • [6] Alloantibodies in von Willebrand disease
    James, Paula D.
    Lillicrap, David
    Mannucci, Pier M.
    BLOOD, 2013, 122 (05) : 636 - 640
  • [7] Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease
    Tout, H
    Obert, B
    Houllier, A
    Fressinaud, E
    Rothschild, C
    Meyer, D
    Girma, JP
    THROMBOSIS AND HAEMOSTASIS, 2000, 83 (02) : 274 - 281
  • [8] Efficacy of emicizumab in a pediatric patient with type 3 von Willebrand disease and alloantibodies
    Weyand, Angela C.
    Flood, Veronica H.
    Shavit, Jordan A.
    Pipe, Steven W.
    BLOOD ADVANCES, 2019, 3 (18) : 2748 - 2750
  • [9] Type 3 Von Willebrand Disease: A Case Report of a Rare Entity
    Phillips, Stephanie
    Lazarchick, John
    Bergmann, Shayla
    BLOOD, 2016, 128 (22)
  • [10] Factor VIII/von Willebrand factorDevelopment of alloantibodies against von Willebrand factor: case report
    Reactions Weekly, 2012, 1426 (1) : 23 - 23
12345